Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Insulet Corp (PODD)

Insulet Corp (PODD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,100,908
  • Shares Outstanding, K 65,651
  • Annual Sales, $ 738,200 K
  • Annual Income, $ 11,600 K
  • 60-Month Beta 0.73
  • Price/Sales 21.45
  • Price/Cash Flow 377.41
  • Price/Book 28.10
Trade PODD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.06
  • Number of Estimates 12
  • High Estimate 0.25
  • Low Estimate -0.04
  • Prior Year 0.09
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
213.51 +16.80%
on 09/24/20
255.39 -2.35%
on 10/14/20
+21.74 (+9.55%)
since 09/23/20
3-Month
189.02 +31.94%
on 07/27/20
255.39 -2.35%
on 10/14/20
+47.77 (+23.69%)
since 07/23/20
52-Week
121.00 +106.11%
on 03/18/20
255.39 -2.35%
on 10/14/20
+102.90 (+70.24%)
since 10/23/19

Most Recent Stories

More News
Quest Diagnostics' (DGX) Q3 Earnings Beat, Base Volume Rises

In Q3, Quest Diagnostics (DGX) sees strong signs of the health care system returning to pre-pandemic levels

DGX : 127.13 (+0.63%)
QDEL : 248.21 (+1.01%)
IDXX : 429.66 (+1.43%)
PODD : 249.39 (+1.69%)
Align Technology (ALGN) Beats on Q3 Earnings, Margins Up

Align Technology's (ALGN) segments report solid rebound in sales across geographies despite the pandemic-led business challenges.

ALGN : 469.56 (+3.60%)
QDEL : 248.21 (+1.01%)
IDXX : 429.66 (+1.43%)
PODD : 249.39 (+1.69%)
Edwards Lifesciences (EW) Beats on Q3 Earnings, Margins Up

Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q3.

EW : 80.41 (+1.30%)
QDEL : 248.21 (+1.01%)
IDXX : 429.66 (+1.43%)
PODD : 249.39 (+1.69%)
Abbott (ABT) Q3 Earnings Top, Diagnostic Test Sales Solid

In Q3, Abbott (ABT) registers solid worldwide adoption of FreeStyle Libre System.

RMD : 183.03 (+0.11%)
ABT : 107.79 (-1.54%)
IDXX : 429.66 (+1.43%)
PODD : 249.39 (+1.69%)
Thermo Fisher (TMO) Q3 Earnings Beat on Life Sciences Sales

Significant COVID-19 led business expansions, as well as Thermo Fisher's (TMO) base business growth contribute to a stunning Q3 performance.

RMD : 183.03 (+0.11%)
TMO : 480.17 (-0.38%)
IDXX : 429.66 (+1.43%)
PODD : 249.39 (+1.69%)
Insulet Appoints Wayne A. I. Frederick, M.D., to Board of Directors

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System (Omnipod System), today announced that Wayne...

PODD : 249.39 (+1.69%)
Shares of PODD Up 28.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Insulet Corp (NASDAQ:PODD) on June 19th, 2020 at $194.82. In approximately 4 months, Insulet Corp has returned 28.46% as of today's recent price of $250.26.

PODD : 249.39 (+1.69%)
The Zacks Analyst Blog Highlights: Zoom Video, Entegris, Copart, Insulet and Intuit

The Zacks Analyst Blog Highlights: Zoom Video, Entegris, Copart, Insulet and Intuit

INTU : 334.42 (+0.78%)
ENTG : 78.35 (-0.36%)
CPRT : 114.29 (+0.18%)
PODD : 249.39 (+1.69%)
ZM : 511.52 (-1.73%)
HEXO in Focus: Stock Moves 5.2% Higher

HEXO saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

PODD : 249.39 (+1.69%)
HEXO : 0.7692 (+2.03%)
Nasdaq Set to Outperform 2019 on Digitization Push: 5 Picks

This year, the technology sector is leading the V-shaped recovery from the unprecedented health-hazard-led economic devastation.

INTU : 334.42 (+0.78%)
ENTG : 78.35 (-0.36%)
CPRT : 114.29 (+0.18%)
PODD : 249.39 (+1.69%)
ZM : 511.52 (-1.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated...

See More

Key Turning Points

2nd Resistance Point 253.54
1st Resistance Point 251.47
Last Price 249.39
1st Support Level 246.87
2nd Support Level 244.34

See More

52-Week High 255.39
Last Price 249.39
Fibonacci 61.8% 204.05
Fibonacci 50% 188.20
Fibonacci 38.2% 172.34
52-Week Low 121.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar